Will GLP-1 agonists help stop or reverse the US obesity trend by end of 2027 | Manifold

Will GLP-1 agonists help stop or reverse the US obesity trend by end of 2027

Plus

31

Ṁ1901

2028

75%

chance

1D

1W

1M

ALL

Will have to adjust resolve date based on when CDC releases the data. If the rate decreases while all the products are pulled from market, or not sold in a reasonable quantity, it won't count.

This question is managed and resolved by Manifold.

Get

1,000

and

3.00

Sort by:

"Help stop" is just . . . the rate goes down at all and we attribute it to GLP-1 agonists? This seems poorly defined.

I assume this resolves positively based entirely on obesity rates in the US, is that correct? I guess if GLP-1 Agonists are entirely pulled from the market it will resolve negatively regardless of obesity rates?

Obesity rates have already been falling in children, teens, and very young adults iirc. We're already past an inflection point.

@jeremiahsamroo Source? I have not heard this.

Related questions

Will a GLP-1 agonist diabetes / weight loss drug be the top bestselling drug in 2025?

Reliable Reporting indicating that more than 3% of Americans are taking GLP-1 agonists in 2024

Will Donald Trump ever take a GLP-1 agonist (eg Ozempic, Mounjaro, Wegovy, Zepbound, etc) for weight loss

Will US obesity decrease by more than 1% before 2030?

Will a clinical trial reporting weight-loss benefits of a GLP-1 agonist be published in a major medical journal in 2024?

Will a GLP-1 receptor agonist (Ozempic-like drug) be added to public water supplies in the United States by 2075?

What fraction of US adults will regularly take GLP-1 drugs in 2030?

Will Ozempic/GLP-1 Agonists become an issue with a clear partisan divide in the US in the next 5 years?

Will US obesity be half or less of the current rate in 2050?

Will Kim Jong Un start taking Ozempic (or any GLP-1) by the end of 2025?

Related questions

Will a GLP-1 agonist diabetes / weight loss drug be the top bestselling drug in 2025?

Will a GLP-1 receptor agonist (Ozempic-like drug) be added to public water supplies in the United States by 2075?

Reliable Reporting indicating that more than 3% of Americans are taking GLP-1 agonists in 2024

What fraction of US adults will regularly take GLP-1 drugs in 2030?

Will Donald Trump ever take a GLP-1 agonist (eg Ozempic, Mounjaro, Wegovy, Zepbound, etc) for weight loss

Will Ozempic/GLP-1 Agonists become an issue with a clear partisan divide in the US in the next 5 years?

Will US obesity decrease by more than 1% before 2030?

Will US obesity be half or less of the current rate in 2050?

Will a clinical trial reporting weight-loss benefits of a GLP-1 agonist be published in a major medical journal in 2024?

Will Kim Jong Un start taking Ozempic (or any GLP-1) by the end of 2025?

© Manifold Markets, Inc.•Terms + Mana-only Terms•Privacy•Rules